Tenderwize
Retour à la recherche

Medicinal products for gene therapies

Dirección General de Recursos Económicos del Servicio Canario de la Salud·Las Palmas de Gran Canaria, Spain·EUR 65.8M·Deadline Apr 17, 2031 · 1700 days left·Restricted·Supplies·DPS
High valueStructured notice only
Titre original de l'avis

Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA

60/100

Score d'opportunité

PromisingMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

60 / 100

Complexité

55 / 100

Facteurs de risque

Selection criteria require annual turnover and references; not meeting thresholds could disqualify.

DPS may have many competitions; each may require separate submission with short deadlines.

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • EUR 65.8M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 2 lots
  • Duration until Apr 2031
  • Supply of advanced gene therapy medicinal products for spinal muscular atrophy and hemophilia B.
  • Destined for patients of the Canary Health Service (Servicio Canario de la Salud).
Afficher le résumé complet

This tender is for a Dynamic Purchasing System (DPS) for the supply of advanced gene therapy medicines for spinal muscular atrophy (SMA) and hemophilia B to patients of the Canary Health Service. The DPS is divided into two lots with a total estimated value of €65,765,376. The procedure is restricted, award is based solely on price (100% weight), and submissions are electronic in Spanish. Tenderers may only bid for one lot.

Risques

Selection criteria require annual turnover and references; not meeting thresholds could disqualify.

DPS may have many competitions; each may require separate submission with short deadlines.

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Administrative

  • Restricted procedure: only invited candidates may submit tenders.
  • Electronic submission is required.
  • All documents must be in Spanish.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

precio. . Precio100%

Lot 2

precio. . Price100%

Acheteur

Localisation

Las Palmas de Gran Canaria, ESP

Profil acheteur

Ouvrir le profil

Identifiant

21058580149618

Activité

Health

Lots (2)

LOT-0001

Terapia génica para la atrofia muscular espinal

Supply of gene therapy for spinal muscular atrophy (SMA).

SuppliesDPSEU fundedElectronic submission

EUR 65.8M

Valeur estimée

Localisation

ES709, Spain

Durée

Apr 2026 - Apr 2031

Catégorie

Medicinal products

Critères d'attribution

precio. . Precio

LOT-0002

Terapia génica para la hemofilia B

Supply of gene therapy for hemophilia B.

SuppliesDPSEU fundedElectronic submission

EUR 65.8M

Valeur estimée

Localisation

ES709, Spain

Durée

Apr 2026 - Apr 2031

Catégorie

Medicinal products

Critères d'attribution

Price

Détails de la procédure

Date de publication
19 Apr 2026
Langues
Spanish

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
267052-2026

Documents (1)

Appels d'offres similaires